Thursday, 14 November 2013

Global Glycated Hemoglobin Testing Market 2012-2016

Reportstack has announced a new market report on Global Glycated Hemoglobin Testing Market 2012-2016 which forecasts that the market is expected to grow at a CAGR of 10.10 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing incidence of diabetes. The Global Glycated Hemoglobin Testing market has also been witnessing the growing use of point of care hemoglobin A1c testing. However, the presence of substitutes could pose a challenge to the growth of this market.

The Global Glycated Hemoglobin Testing Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Glycated Hemoglobin Testing market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this market space are Abbott Laboratories, Alere Inc., Beckman Coulter Inc. and Roche Holdings AG.

Other vendors mentioned in the report are ARKRAY Inc., A. Menarini Diagnostics Ltd., Bayer AG, Bio-Rad Laboratories Inc., Diazyme Laboratories Inc., Pointe Scientific Inc., Randox Laboratories Ltd., Roche Holdings AG, Trinity Biotech plc, and Tosoh Corp.

Key questions answered in this report:

What will the market size be in 2016 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

To view the table of contents and know more details please visit Global Glycated Hemoglobin Testing Market 2012-2016 report.

No comments:

Post a Comment